ArticleJournal of experimental & clinical cancer research : CR2021

Efficacy and mechanism of the combination of PARP and CDK4/6 inhibitors in the treatment of triple-negative breast cancer.

Xiuzhi Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.